2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$15.58+$0.20 (+1.30%)
Price as of Jun 23, 2026 6:51 PM EDT- $17.9BMarket Cap
- 80.63%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$15.58+$0.20 (+1.30%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.38 | ||
Change | +$0.01 (+0.07%) | ||
Open | $15.45 | ||
High | $15.52 | ||
Low | $15.07 | ||
Previous Close | $15.37 | ||
Volume | 12,531,214 | ||
30-Day Average Volume | 10,199,997 | ||
1-Week Change | -5.76% | ||
1-Month Change | -7.63% | ||
1-Year Change | 80.63% | ||
3-Year Change | 74.17% | ||
5-Year Change | 33.48% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $36.8B | ||
Market Cap | $17.9B | ||
Enterprise Value | $30.5B | ||
Period: QTR TTM FY | |||
Revenue | $3.5B | ||
Net Income | $176.4M | ||
Free Cash Flow | $348.4M | ||
EBIT | -$127.2M | ||
EBITDA | $548.9M | ||
Net Working Capital | $4.1B | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 55 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | 103 | ||
PEG | 1 | ||
Price/Free Cash Flow | 51 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 3.12% | ||
Trailing Annual Dividend Yield | 3.12% | ||
Ex-Dividend Date | 05/22/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield